Skip to content

ETIS PHARMA

Active
Private limited companyfounded 2018active for 8 yearsPlace du Marais(PAC) 2, 6230 Pont-à-Celles, BelgiumKBO/BCE: BE 0702.914.656

Acts, filings and financial milestones

Deadline for the 2027 accounts: 31-08-2027
2026
07-05
NBB filing Annual accounts 2026 filedPDF
full format · 116 days before the deadline
2025
18-07
NBB filing Annual accounts 2025 filedPDF
full format · 44 days before the deadline
2024
24-07
NBB filing Annual accounts 2024 filedPDF
full format · 38 days before the deadline
2023
10-10
Gazette deed Change of role: EVRARD,Etienne, from manager to director
Amendment of the articles · Capital conversion · Capital9 points ▸
  • General meeting, “assemblée générale extraordinaire des associés” (deed in French)
  • Amendment of the articles, mentioned 2 times in the deed
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Capital
  • Power of attorney, Jean-Benoît JONCKHEERE
  • Director resignation, EVRARD,Etienne (manager)
  • Director appointment, EVRARD,Etienne (director (not named in the articles))
  • Director discharge, EVRARD,Etienne (gérant démissionnaire)
  • Registered office clause, “6230 Pont-à-Celles,Place du Marais 2” (deed in French)

Open the act in the Belgian Official Gazette

24-07
NBB filing Annual accounts 2023 filedPDF
full format · 38 days before the deadline
31-01
Financial Equity above €150,000equity €191,879 ▲44.7%
After 3 profitable years in a row, equity reaches €191,879.
2022
19-10
NBB filing Annual accounts 2022 filedPDF
micro format · 49 days late
31-01
Financial Highest result from 2020 to 2026net €114,729 ▲324%
The operating result of €149,878 and the net result of €114,729 are both a record.
31-01
Financial Liquidity doublescurrent ratio 1.34
The current ratio rises from 0.66 to 1.34.
31-01
Financial Equity above €100,000equity €132,633 ▲641%
After 2 profitable years in a row, equity reaches €132,633.
2021
24-08
NBB filing Annual accounts 2021 filedPDF
micro format · 7 days before the deadline
31-01
Financial Back to profitnet €27,060
The net result is €27,060, after one loss-making year.
2020
03-08
NBB filing Annual accounts 2020 filedPDF
micro format · 28 days before the deadline
2018
11-09
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 7 September 2018, ETIS PHARMA was incorporated.1 Total assets went from €541,389 in 2020 to €599,365 in 2026 and headcount from 1.3 to 3.5 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2020 and 2026

Next steps